These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19309242)

  • 1. Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes.
    Warkentin TE; Greinacher A
    Expert Opin Drug Saf; 2009 Mar; 8(2):129-44. PubMed ID: 19309242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anaphylactoid reactions associated with contaminated heparin from China].
    Montpas N; Désormeaux A; Keire D; Adam A
    Ann Pharm Fr; 2011 Sep; 69(5):258-64. PubMed ID: 21924126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contaminated heparin associated with adverse clinical events and activation of the contact system.
    Kishimoto TK; Viswanathan K; Ganguly T; Elankumaran S; Smith S; Pelzer K; Lansing JC; Sriranganathan N; Zhao G; Galcheva-Gargova Z; Al-Hakim A; Bailey GS; Fraser B; Roy S; Rogers-Cotrone T; Buhse L; Whary M; Fox J; Nasr M; Dal Pan GJ; Shriver Z; Langer RS; Venkataraman G; Austen KF; Woodcock J; Sasisekharan R
    N Engl J Med; 2008 Jun; 358(23):2457-67. PubMed ID: 18434646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro.
    Adam A; Montpas N; Keire D; Désormeaux A; Brown NJ; Marceau F; Westenberger B
    Biomaterials; 2010 Aug; 31(22):5741-8. PubMed ID: 20427081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oversulfated chondroitin sulfate and OSCS-contaminated heparin cause dose- and route-dependent hemodynamic effects in the rat.
    Corbier A; Le Berre N; Rampe D; Meng H; Lorenz M; Vicat P; Potdevin S; Doubovetzky M
    Toxicol Sci; 2011 Jun; 121(2):417-27. PubMed ID: 21436127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outbreak of adverse reactions associated with contaminated heparin.
    Blossom DB; Kallen AJ; Patel PR; Elward A; Robinson L; Gao G; Langer R; Perkins KM; Jaeger JL; Kurkjian KM; Jones M; Schillie SF; Shehab N; Ketterer D; Venkataraman G; Kishimoto TK; Shriver Z; McMahon AW; Austen KF; Kozlowski S; Srinivasan A; Turabelidze G; Gould CV; Arduino MJ; Sasisekharan R
    N Engl J Med; 2008 Dec; 359(25):2674-84. PubMed ID: 19052120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cytokine secretion from lymphocytes of patients with hypersensitivity reactions to contaminated heparins.
    Martin M; Ott H; Merk HF; Sachs B
    Br J Dermatol; 2011 Jan; 164(1):68-75. PubMed ID: 20854434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins.
    Li B; Suwan J; Martin JG; Zhang F; Zhang Z; Hoppensteadt D; Clark M; Fareed J; Linhardt RJ
    Biochem Pharmacol; 2009 Aug; 78(3):292-300. PubMed ID: 19389385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin and oversulfated heparin byproduct induce thrombin generation through contact system activation in plasma of patients with HIT.
    Yi Qian ; Jing Pan ; Xiaodong Zhou ; Weiser P; Hong Lu ; Shih FF; Porche-Sorbet R; Eby C; Lijuan Zhang
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):251-60. PubMed ID: 20460351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons learned from the contamination of heparin.
    Liu H; Zhang Z; Linhardt RJ
    Nat Prod Rep; 2009 Mar; 26(3):313-21. PubMed ID: 19240943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Artificial polysaccharide in contaminated heparin. Acute hypersensitivity reactions explained--but how could it happen?].
    Lindahl U
    Lakartidningen; 2008 Sep 24-30; 105(39):2660-1. PubMed ID: 18846871
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatal anaphylactoid reaction associated with heparin-induced thrombocytopenia.
    Singla A; Amini MR; Alpert MA; Gornik HL
    Vasc Med; 2013 Jun; 18(3):136-8. PubMed ID: 23579400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contaminated heparin.
    Greinacher A; Warkentin TE
    N Engl J Med; 2008 Sep; 359(12):1291-2; author reply 1293. PubMed ID: 18799565
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study.
    Warkentin TE; Roberts RS; Hirsh J; Kelton JG
    Chest; 2005 May; 127(5):1857-61. PubMed ID: 15888871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure elucidation and biological activity of the oversulfated chondroitin sulfate contaminant in Baxter heparin.
    McKee J; Bairstow S; Szabo C; Ray J; Wielgos T; Hu P; Chess E; Nordhaus M; Hai T; Campbell J; Donovan S; Viseux N; Riedel N; Cammack J; Johnson R
    J Clin Pharmacol; 2010 Oct; 50(10):1159-70. PubMed ID: 20147614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: contaminants in heparin: review of the literature, molecular profiling, and clinical implications.
    Ramacciotti E; Clark M; Sadeghi N; Hoppensteadt D; Thethi I; Gomes M; Fareed J
    Clin Appl Thromb Hemost; 2011 Apr; 17(2):126-35. PubMed ID: 21288929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia.
    Greinacher A; Lubenow N; Eichler P
    Circulation; 2003 Oct; 108(17):2062-5. PubMed ID: 14568897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oversulfated chondroitin sulfate inhibits the complement classical pathway by potentiating C1 inhibitor.
    Zhou ZH; Rajabi M; Chen T; Karnaukhova E; Kozlowski S
    PLoS One; 2012; 7(10):e47296. PubMed ID: 23077587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008.
    McMahon AW; Pratt RG; Hammad TA; Kozlowski S; Zhou E; Lu S; Kulick CG; Mallick T; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):921-33. PubMed ID: 20661880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shake it off: A curious case of rigors.
    Han S; John S; Jackson CD
    J Natl Med Assoc; 2023 Jun; 115(3):333-336. PubMed ID: 37087353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.